1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Graft Occlusion, Vascular in 3 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimoto, M | 1 |
| Yamanouchi, D | 1 |
| Komori, K | 1 |
| Ding, R | 1 |
| Hu, DY | 1 |
| Xia, K | 1 |
| Yang, XC | 1 |
| Hattori, T | 1 |
| Shimokawa, H | 1 |
| Higashi, M | 1 |
| Hiroki, J | 1 |
| Mukai, Y | 1 |
| Kaibuchi, K | 1 |
| Takeshita, A | 1 |
1 review available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic beta-Antagonists; Animals; Arginine; Cell | 2009 |
2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Increased RhoA/ROK mRNA expression and function in diabetic vein grafts compared with nondiabetic vein grafts and diabetic arterial grafts.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Case-Control Studies; Coronary Artery By | 2010 |
Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenoviridae; Animals; Cell Movement; Coronary Artery | 2004 |